Loading clinical trials...
Loading clinical trials...
Combination With Intravenous Iron Supplementation or Doubling Erythropoietin Dose for Patients With Chemotherapy-induced Anaemia Inadequately Responsive to Initial Erythropoietin Treatment Alone
Conditions
Interventions
Erythropoietins (EPO)
Aggressive iron dextran supplementation
+2 more
Locations
6
China
Shanghai East Hospital Home Branch
Shanghai, Shanghai Municipality, China
Shanghai East Hospital South Branch
Shanghai, Shanghai Municipality, China
Shanghai First People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai Sixth People's Hospital Lingang Branch
Shanghai, Shanghai Municipality, China
The First Affiliated Hospital, The Second Military Medical University
Shanghai, Shanghai Municipality, China
Shanghai East Hospital Jian Branch
Jian, Zhejiang, China
Start Date
December 1, 2016
Primary Completion Date
April 1, 2019
Completion Date
November 1, 2019
Last Updated
November 1, 2016
Lead Sponsor
Shanghai East Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions